Clinical Trials Browser

INDUSTRY × Head and Neck Neoplasms × GSK 1363089 × Clear all

NCT00725764 2017-10-16

Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck

Phase 2 Completed

14 enrolled 14 charts

Head and Neck Neoplasms